hg_100666.1

Basic information about the TSS

---

TSS ID: hg_100666.1 Species: human Chr: chr9		Start: 35814988 End: 35815008 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000472085.5 AK222582 Distance: 0 GeneID: 84681 HGNC/MGI_ID: HGNC:18344 UniProt_ID: Q53HJ8

Gene_name: histidine triad nucleotide binding protein 2 Gene_symbol: HINT2 Gene_synonyms: Gene_source: HGNC:18344

TATA-Box annotation

---

Distance to TSS:	44
Nearest PromoterID:	NM_032593
Entrez ID:	84681
Nearest Unigene:	Hs.70573
Nearest Refseq:	NM_032593
Nearest Ensembl:	ENSG00000137133
Gene Name:	histidine triad nucleotide binding protein 2
Gene Alias:	HIT-17
Gene Description:	histidine triad nucleotide binding protein 2
Gene Type:	protein-coding
CpG%:	0.135
GC%:	0.78607
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HINT2 p2@HINT2 p3@HINT2
Sample		p1@HINT2	p2@HINT2	p3@HINT2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	13.05	3.12	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	14.36	3.24	2.83
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.35	3.47	2.12
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	11.44	4.16	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	13.27	4.50	3.15
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	11.63	2.71	3.10
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	21.35	4.58	3.92
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	14.29	4.60	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	16.03	2.99	1.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	19.71	6.38	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	13.34	4.04	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.57	3.66	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	13.22	4.35	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.33	3.76	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.05	3.73	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	9.31	4.28	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.79	3.49	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.97	2.11	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	14.40	3.20	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	19.11	4.21	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	14.30	3.34	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.26	3.45	2.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	11.37	3.49	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	13.35	5.34	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	12.90	5.16	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	15.83	1.27	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.99	3.30	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.27	4.72	2.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	16.80	2.91	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	14.66	2.90	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.00	2.72	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.57	2.34	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.82	3.38	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	12.04	3.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	14.96	4.11	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	12.07	3.07	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.83	3.47	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.47	3.22	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.61	4.32	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	11.52	3.84	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	13.65	3.29	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	8.49	2.34	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	7.38	2.53	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	9.79	4.02	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	10.24	2.61	2.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	12.80	5.12	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	13.43	3.84	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	11.03	2.68	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	7.42	1.20	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.47	2.02	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	8.40	2.66	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	10.45	4.00	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.23	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	8.62	3.31	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	1.68	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.73	3.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.16	1.94	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	7.07	2.25	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	7.86	1.89	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.94	2.82	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.17	0.56	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	4.78	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	6.46	1.70	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.80	2.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.52	2.84	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	5.36	1.95	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.94	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	5.63	1.88	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.58	1.99	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.21	1.55	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	11.01	1.53	1.53
Adipocyte - breast, donor1	11376-118A8	8.39	3.64	2.38
Adipocyte - breast, donor2	11327-117E4	18.13	4.01	2.41
Adipocyte - omental, donor1	11473-119C6	10.81	2.67	2.29
Adipocyte - omental, donor2	11474-119C7	12.71	4.48	2.99
Adipocyte - omental, donor3	11475-119C8	15.07	6.36	2.01
Adipocyte - perirenal, donor1	11476-119C9	11.48	8.29	3.83
Adipocyte - subcutaneous, donor1	11259-116F8	50.58	9.90	8.80
Adipocyte - subcutaneous, donor2	11336-117F4	7.68	4.06	2.26
Adipocyte - subcutaneous, donor3	11408-118E4	34.06	3.13	4.52
Adipocyte differentiation, day04, donor1	13019-139D4	15.25	4.50	2.74
Adipocyte differentiation, day04, donor2	13022-139D7	7.72	4.12	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	25.65	8.92	3.35
Adipocyte differentiation, day04, donor4	13028-139E4	25.86	5.29	7.64
Adipocyte differentiation, day08, donor1	13020-139D5	41.50	7.96	5.87
Adipocyte differentiation, day08, donor2	13023-139D8	20.66	5.49	3.55
Adipocyte differentiation, day08, donor3	13026-139E2	21.33	4.27	2.67
Adipocyte differentiation, day08, donor4	13029-139E5	30.05	8.35	6.12
Adipocyte differentiation, day12, donor1	13021-139D6	103.56	15.39	12.89
Adipocyte differentiation, day12, donor2	13024-139D9	26.12	5.53	5.27
Adipocyte differentiation, day12, donor3	13027-139E3	41.89	4.58	3.93
Adipocyte differentiation, day12, donor4	13030-139E6	47.80	6.39	6.09
Alveolar Epithelial Cells, donor1	11510-119G7	17.46	4.20	4.42
Alveolar Epithelial Cells, donor2	11590-120G6	43.75	9.68	3.59
Alveolar Epithelial Cells, donor3	11671-122G6	21.56	4.79	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	12.95	3.24	3.24
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	14.79	3.70	1.64
Anulus Pulposus Cell, donor1	11248-116E6	15.33	8.01	5.49
Anulus Pulposus Cell, donor2	11463-119B5	17.88	7.35	3.18
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	12.58	4.04	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	12.59	1.30	2.60
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	6.88	2.99	2.69
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	15.18	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	14.52	2.64	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	8.12	1.95	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	12.14	1.94	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	9.50	5.94	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	10.55	1.13	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	9.43	1.45	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	1.25	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.53	3.46	1.65
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	4.09	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	11.61	3.47	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.04	2.68	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.88	3.02	1.89
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	9.62	4.81	2.41
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	10.73	3.90	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.13	1.99	2.49
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	2.40	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	3.54	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.43	2.74	1.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.19	3.88	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	12.14	1.90	2.28
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	26.65	6.06	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.12	2.85	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	12.40	2.99	1.92
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.58	3.61	1.81
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.98	3.28	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.68	0.96	3.22
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.27	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.11	1.17	2.92
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.92	2.11	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	3.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	11.70	2.03	4.07
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	11.46	4.33	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	13.34	1.91	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	8.63	3.88	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.53	4.66	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.60	2.61	2.32
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	8.50	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	10.34	2.37	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	6.95	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	7.50	2.57	1.72
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.03	0.60	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	7.29	1.46	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.74	2.99	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	12.20	4.32	3.05
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	8.88	3.92	2.06
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	10.40	3.67	2.45
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	10.99	1.91	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.53	0.89	1.55
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	12.21	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.29	3.32	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	10.86	2.38	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	11.27	2.91	0.36
Astrocyte - cerebellum, donor1	11500-119F6	25.91	9.58	6.14
Astrocyte - cerebellum, donor2	11580-120F5	30.98	8.04	5.31
Astrocyte - cerebellum, donor3	11661-122F5	28.74	5.45	3.99
Astrocyte - cerebral cortex, donor1	11235-116D2	34.16	6.62	4.53
Astrocyte - cerebral cortex, donor2	11316-117D2	24.59	4.21	4.21
Astrocyte - cerebral cortex, donor3	11392-118C6	34.01	7.91	4.77
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	17.89	5.85	2.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	17.16	5.64	2.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	19.35	6.15	3.87
Basophils, donor1	12241-129G9	7.32	4.97	1.31
Basophils, donor2	12242-129H1	7.22	2.53	0.72
Basophils, donor3	12243-129H2	9.41	3.23	1.47
Bronchial Epithelial Cell, donor1	11511-119G8	12.72	2.80	2.16
Bronchial Epithelial Cell, donor2	11591-120G7	26.06	3.20	2.74
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	27.62	3.77	5.65
Bronchial Epithelial Cell, donor5	11457-119A8	17.26	3.54	4.16
Bronchial Epithelial Cell, donor6	11461-119B3	21.65	4.38	2.30
Bronchial Epithelial Cell, donor7	11769-123I5	13.50	0.90	2.70
Burkitt's lymphoma cell line:DAUDI	10422-106C8	20.71	3.92	1.96
Burkitt's lymphoma cell line:RAJI	10476-106I8	19.80	5.36	2.56
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.86	14.71	8.95
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	20.68	10.34
CD14+ Monocytes, donor1	11224-116B9	10.14	1.69	1.13
CD14+ Monocytes, donor2	11305-117B9	5.20	2.23	0.37
CD14+ Monocytes, donor3	11381-118B4	6.15	2.41	1.32
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	15.28	6.23	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	17.44	5.69	1.90
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	12.49	4.27	1.97
CD14+ monocytes - mock treated, donor1	11863-125A9	3.47	0.72	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	1.81	1.51	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	1.90	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.18	1.51	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2.48	0.00	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.21	1.49	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.68	1.37	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.99	0.89	1.07
CD14+ monocytes - treated with BCG, donor3	11880-125C8	7.83	1.52	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.28	0.70	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2.11	0.53	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.31	0.74	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2.79	0.60	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	4.37	0.83	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.69	0.92	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	3.62	0.90	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	2.62	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.92	1.08	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	4.88	0.87	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	4.63	1.68	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.78	1.47	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.28	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.07	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	3.31	1.22	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.20	1.86	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	5.39	1.72	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.55	2.05	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	2.32	0.46	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	5.10	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	10.24	6.10	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	10.39	6.24	2.77
CD14+CD16+ Monocytes, donor3	11912-125G4	13.86	3.90	1.52
CD14+CD16- Monocytes, donor1	11788-124B6	14.95	9.65	2.65
CD14+CD16- Monocytes, donor2	11799-124C8	14.15	4.19	1.75
CD14+CD16- Monocytes, donor3	11910-125G2	7.36	4.24	2.01
CD14-CD16+ Monocytes, donor1	11790-124B8	15.57	6.63	3.57
CD14-CD16+ Monocytes, donor2	11800-124C9	12.73	3.73	1.98
CD14-CD16+ Monocytes, donor3	11911-125G3	15.37	4.21	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	40.65	8.13	6.10
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	35.93	10.17	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	29.00	10.36	4.14
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	23.45	14.93	5.33
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	49.85	12.87	3.75
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	30.18	14.04	4.91
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	33.73	10.20	5.49
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	39.55	15.82	13.18
CD19+ B Cells, donor1	11544-120B5	4.93	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	10.88	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	7.07	1.51	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	45.25	10.91	9.70
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	52.73	14.38	7.99
CD34+ Progenitors, donor1	11545-120B6	14.06	13.05	4.02
CD34+ Progenitors, donor2	11625-122B5	12.36	3.93	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	37.95	8.64	6.76
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	45.10	12.18	5.86
CD4+ T Cells, donor1	11225-116C1	8.21	2.50	1.07
CD4+ T Cells, donor2	11306-117C1	12.86	3.06	3.67
CD4+ T Cells, donor3	11382-118B5	12.81	3.35	1.52
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	27.31	8.17	4.34
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	28.52	8.76	2.47
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	28.46	8.34	4.02
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	16.12	6.16	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	37.22	7.73	4.92
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	3.30	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	26.45	15.17	5.06
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	31.52	11.35	4.74
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	30.15	10.64	3.39
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	21.07	9.86	4.03
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	26.20	8.39	5.94
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	23.76	5.28	4.40
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	32.04	13.91	4.22
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	39.27	12.47	5.82
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	37.42	19.38	8.35
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	16.32	3.54	2.72
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	18.76	9.11	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	14.35	5.38	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	35.60	21.14	7.42
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	30.76	17.11	5.63
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	39.30	15.13	7.78
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	32.86	7.58	2.53
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	29.89	6.50	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	15.69	5.23	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	35.63	10.39	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	43.39	21.23	8.31
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	51.65	27.92	6.98
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	27.42	8.31	3.32
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	32.39	7.36	5.15
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	44.66	13.86	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	27.22	11.10	3.58
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	37.39	16.62	5.54
CD8+ T Cells, donor1	11226-116C2	12.11	2.29	2.29
CD8+ T Cells, donor2	11307-117C2	10.89	3.00	1.50
CD8+ T Cells, donor3	11383-118B6	14.14	2.78	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	22.02	10.78	6.19
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	20.37	9.83	5.75
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	22.98	9.03	3.56
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.31	5.40	3.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	21.60	11.04	4.08
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	23.19	10.46	5.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	26.51	11.52	6.74
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	21.85	11.05	5.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	20.87	11.02	4.92
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	26.57	15.09	6.04
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	28.76	13.36	5.23
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	25.31	13.06	8.79
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	15.76	7.88	4.38
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	20.49	7.29	2.73
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	15.66	9.70	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.53	9.72	4.68
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	24.46	11.80	2.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	22.63	11.78	5.19
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	30.11	11.09	5.39
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	21.84	10.46	6.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	26.93	6.09	3.85
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	35.95	10.71	6.12
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	26.01	16.16	4.73
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	17.40	10.59	6.05
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	30.51	6.42	5.62
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	18.88	10.49	4.90
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	33.06	13.02	2.00
Cardiac Myocyte, donor1	11525-119I4	1.83	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	9.88	6.92	2.96
Cardiac Myocyte, donor3	11686-122I3	12.42	4.31	1.37
Chondrocyte - de diff, donor1	11261-116G1	21.15	2.43	5.20
Chondrocyte - de diff, donor2	11338-117F6	12.08	3.91	2.49
Chondrocyte - de diff, donor3	11410-118E6	13.77	5.01	2.96
Chondrocyte - re diff, donor2	11339-117F7	11.64	2.69	0.90
Chondrocyte - re diff, donor3	11411-118E7	17.79	0.81	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	25.48	6.66	3.21
Ciliary Epithelial Cells, donor2	11323-117D9	19.45	4.92	3.21
Ciliary Epithelial Cells, donor3	11399-118D4	19.56	4.96	2.74
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	27.14	9.54	5.87
Corneal Epithelial Cells, donor1	11526-119I5	20.86	4.17	3.51
Corneal Epithelial Cells, donor2	11606-120I4	31.85	3.41	1.14
Corneal Epithelial Cells, donor3	11687-122I4	29.91	4.35	4.35
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	5.94	3.96	1.32
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	9.78	5.99	2.21
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	6.90	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.24	2.81	1.30
Dendritic Cells - plasmacytoid, donor1	11228-116C4	23.91	11.62	4.44
Dendritic Cells - plasmacytoid, donor2	11309-117C4	49.62	18.28	8.49
Dendritic Cells - plasmacytoid, donor3	11385-118B8	36.78	15.49	7.74
Endothelial Cells - Aortic, donor0	11207-116A1	15.51	3.00	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	9.98	2.35	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	8.20	1.70	2.83
Endothelial Cells - Aortic, donor3	11412-118E8	11.80	3.54	1.97
Endothelial Cells - Artery, donor1	11264-116G4	8.14	2.33	1.16
Endothelial Cells - Artery, donor2	11341-117F9	9.41	1.88	1.88
Endothelial Cells - Artery, donor3	11413-118E9	13.32	2.10	1.93
Endothelial Cells - Lymphatic, donor1	11236-116D3	7.31	0.22	1.33
Endothelial Cells - Lymphatic, donor2	11317-117D3	5.48	2.13	1.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	2.82	1.13	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	9.51	1.49	2.08
Endothelial Cells - Microvascular, donor2	11342-117G1	4.17	1.04	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	6.10	0.57	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	7.60	2.00	3.60
Endothelial Cells - Thoracic, donor2	11343-117G2	9.43	2.10	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	14.91	5.59	2.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	16.51	3.26	2.39
Endothelial Cells - Umbilical vein, donor3	11400-118D5	18.44	4.27	2.08
Endothelial Cells - Vein, donor1	11267-116G7	12.51	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	9.08	1.40	3.49
Endothelial Cells - Vein, donor3	11416-118F3	11.62	2.04	1.10
Eosinophils, donor1	12244-129H3	15.25	0.00	15.25
Eosinophils, donor2	12245-129H4	1.65	0.00	1.65
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	17.10	2.93	3.18
Esophageal Epithelial Cells, donor2	11587-120G3	18.72	0.00	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	9.85	4.93	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.55	2.96	0.99
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	18.74	5.31	2.17
Fibroblast - Aortic Adventitial, donor1	11245-116E3	12.61	3.88	2.67
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	3.00	1.91	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	7.28	2.00	1.69
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	6.06	1.58	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	11.96	5.32	2.99
Fibroblast - Cardiac, donor1	11268-116G8	9.98	6.35	2.27
Fibroblast - Cardiac, donor2	11345-117G4	18.19	3.03	2.27
Fibroblast - Cardiac, donor3	11417-118F4	15.14	4.10	2.52
Fibroblast - Cardiac, donor4	11452-119A3	4.55	5.15	1.21
Fibroblast - Cardiac, donor5	11456-119A7	17.77	5.46	3.93
Fibroblast - Cardiac, donor6	11460-119B2	16.68	4.55	2.27
Fibroblast - Choroid Plexus, donor1	11492-119E7	9.92	3.62	1.47
Fibroblast - Choroid Plexus, donor2	11572-120E6	5.61	4.31	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	2.93	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	33.67	9.46	6.00
Fibroblast - Conjunctival, donor3	11692-122I9	7.12	3.05	2.54
Fibroblast - Dermal, donor1	11269-116G9	8.45	2.58	0.94
Fibroblast - Dermal, donor2	11346-117G5	10.85	2.83	3.77
Fibroblast - Dermal, donor3	11418-118F5	8.34	3.14	1.21
Fibroblast - Dermal, donor4	11450-119A1	20.57	4.52	4.18
Fibroblast - Dermal, donor5	11454-119A5	21.11	4.01	3.66
Fibroblast - Dermal, donor6	11458-119A9	21.28	6.01	3.25
Fibroblast - Gingival, donor1	11237-116D4	12.70	5.00	3.75
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	16.51	4.98	3.93
Fibroblast - Gingival, donor2	11318-117D4	20.16	5.27	2.64
Fibroblast - Gingival, donor3	11394-118C8	16.34	4.25	2.90
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	9.35	5.19	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	10.40	4.23	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	26.81	8.11	3.12
Fibroblast - Gingival, donor6 (control)	11922-125H5	18.93	7.30	3.25
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	8.82	2.82	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	17.55	7.31	3.66
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	20.04	8.18	4.50
Fibroblast - Gingival, donor8 (control)	11926-125H9	23.47	5.37	2.96
Fibroblast - Gingival, donor9 (control)	11927-125I1	8.51	4.70	1.91
Fibroblast - Lung, donor1	11270-116H1	14.95	4.08	1.36
Fibroblast - Lung, donor2	11347-117G6	8.95	5.97	1.49
Fibroblast - Lung, donor3	11419-118F6	13.51	4.43	2.74
Fibroblast - Lymphatic, donor1	11506-119G3	14.99	10.83	3.33
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	2.80	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	10.36	1.96	3.92
Fibroblast - Mammary, donor1	11540-120B1	12.59	5.28	2.84
Fibroblast - Mammary, donor2	11620-122A9	11.98	7.99	11.98
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	25.60	5.24	3.49
Fibroblast - Periodontal Ligament, donor2	11319-117D5	16.53	4.55	2.88
Fibroblast - Periodontal Ligament, donor3	11395-118C9	8.87	2.14	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.12	4.58	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.23	5.13	3.51
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	13.92	3.94	1.86
Fibroblast - Pulmonary Artery, donor1	11250-116E8	11.94	6.08	2.21
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	13.00	4.67	4.27
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	18.71	6.01	6.68
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	16.61	5.93	1.98
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	4.96	0.60	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.77	2.31	1.78
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	7.29	1.97	1.77
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	6.32	2.41	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	10.69	3.99	2.70
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	7.09	2.28	0.76
Fibroblast - skin normal, donor1	11553-120C5	10.01	5.25	2.63
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	5.21	2.21	1.20
Fibroblast - skin normal, donor2	11561-120D4	11.95	3.72	1.71
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	9.37	2.42	2.42
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	8.86	3.40	2.24
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	14.53	3.08	2.56
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	4.93	1.64	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	13.85	4.90	2.66
Fibroblast - skin walker warburg, donor1	11554-120C6	12.31	4.72	2.19
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.10	1.88	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.94	3.49	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	9.19	2.08	1.56
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	8.07	1.56	2.08
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	8.43	2.30	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	28.33	9.19	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.16	5.10	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	39.37	4.85	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	43.02	3.86	4.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	31.28	4.11	2.51
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	35.66	2.58	2.58
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	47.05	3.44	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	37.83	3.91	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	37.15	1.77	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	20.77	1.98	2.97
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	20.07	1.97	1.97
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	20.15	1.61	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	19.33	2.60	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	19.79	3.32	2.08
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	14.03	2.03	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	22.36	2.51	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	19.68	2.87	2.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	15.74	2.40	1.97
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	30.43	3.55	3.25
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	24.48	3.02	2.86
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	21.00	3.13	1.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	23.59	4.84	2.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	25.11	5.09	2.71
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	15.96	3.99	2.57
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.71	2.39	1.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.88	3.59	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	19.03	2.99	1.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.88	4.58	2.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	16.95	2.86	2.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.25	3.30	2.48
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	18.56	2.54	2.31
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	18.84	3.84	2.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	15.43	3.75	2.42
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	21.77	3.07	2.46
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	17.99	4.21	2.27
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	24.05	1.92	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	17.91	4.83	1.61
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	14.39	4.43	2.85
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	19.46	0.61	2.43
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	19.65	3.87	3.03
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	18.00	5.49	2.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	20.48	3.09	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.67	4.17	1.85
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	14.17	2.41	2.94
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	14.23	4.13	3.37
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	14.25	5.05	2.85
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	14.10	5.42	2.71
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	12.17	2.95	1.47
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	11.40	1.97	1.97
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	9.92	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	10.82	2.37	1.32
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	13.72	2.82	2.22
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	5.34	1.78	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	20.11	1.19	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	15.41	1.23	1.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	18.41	2.25	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	42.25	9.39	3.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	40.41	6.50	4.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	33.21	5.53	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	7.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	37.13	4.64	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	4.81	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	3.48	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	28.64	6.18	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	30.47	6.59	3.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	28.24	5.03	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	26.80	3.60	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	31.88	6.71	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	27.04	3.18	3.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	28.19	6.11	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	43.85	10.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	34.93	4.01	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	33.74	5.03	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	32.19	5.08	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	33.14	8.70	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	33.83	5.98	3.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	5.27	21.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.91	4.61	4.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	33.57	6.85	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	43.47	6.69	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	33.52	4.24	3.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	23.62	2.74	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	32.30	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	26.42	2.83	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	34.40	5.43	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	35.61	8.14	3.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	30.31	3.99	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	29.60	3.95	5.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	49.58	7.08	5.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	43.76	6.42	4.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	22.82	2.63	3.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	24.58	3.39	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	37.01	7.76	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	31.54	6.79	4.37
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	13.70	10.27	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.15	1.25	2.91
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	25.86	5.62	4.50
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	7.29	2.22	1.90
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	7.94	3.34	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	35.74	9.52	7.31
Hep-2 cells mock treated, biol_rep2	11899-125E9	29.20	13.84	8.61
Hep-2 cells mock treated, biol_rep3	11900-125F1	25.03	6.14	5.92
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	33.23	10.38	5.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	28.15	10.96	7.95
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	24.76	9.69	6.89
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	31.88	10.46	6.85
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	30.36	9.09	7.21
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	22.75	7.37	8.97
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.63	0.56	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	12.98	2.16	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	15.87	5.29	4.59
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	17.44	5.81	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	20.63	6.82	3.85
Hepatocyte, donor1	11523-119I2	76.27	14.53	6.05
Hepatocyte, donor2	11603-120I1	73.26	8.62	7.54
Hepatocyte, donor3	11684-122I1	57.06	11.66	6.14
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	58.74	20.23	6.53
Intestinal epithelial cells (polarized), donor1	11246-116E4	34.08	5.77	4.19
Iris Pigment Epithelial Cells, donor1	11530-119I9	10.84	2.47	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	41.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	20.03	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	13.84	4.15	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	5.01	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	5.13	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	24.36	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	1.67	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	10.89	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	21.18	3.97	5.29
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	14.41	8.87	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	5.24	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	21.42	6.30	5.04
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	0.00	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	20.67	5.81	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	16.10	4.83	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	23.90	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	26.89	3.26	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	22.67	6.72	4.62
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	17.68	7.23	4.82
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	20.31	1.85	5.54
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	20.30	3.30	6.14
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	19.05	1.81	4.53
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	29.48	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	19.37	5.38	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	21.60	5.08	5.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	32.86
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	19.13	8.93	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	20.05	3.65	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	22.85	5.00	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	9.95	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	41.70
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	16.05	4.32	3.40
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	1.76	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	28.29	3.14	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	17.38	4.17	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	6.64	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	9.73	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	32.26	9.59	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	45.00	4.50	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	10.45	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	34.14	10.67	6.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	20.78	2.77	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	5.70	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	28.53	6.44	7.36
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	42.35	3.03	12.10
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	31.72	5.29	4.23
Keratinocyte - epidermal, donor1	11272-116H3	7.51	1.39	1.47
Keratinocyte - epidermal, donor2	11349-117G8	11.71	2.34	3.51
Keratinocyte - epidermal, donor3	11421-118F8	17.98	2.37	2.84
Keratinocyte - oral, donor1	11251-116E9	20.32	2.16	3.52
Keratocytes, donor1	11527-119I6	33.35	10.31	6.88
Keratocytes, donor2	11607-120I5	31.64	4.69	5.86
Keratocytes, donor3	11688-122I5	17.19	3.95	2.17
Krukenberg tumor cell line:HSKTC	10687-109F3	81.32	24.18	4.40
Lens Epithelial Cells, donor1	11529-119I8	12.94	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	16.72	2.42	2.31
Lens Epithelial Cells, donor3	11690-122I7	12.11	2.83	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	6.28	1.07	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.37	1.95	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	5.19	1.73	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.07	2.15	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	6.93	1.26	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.12	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	3.69	0.82	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.85	1.52	1.52
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.88	1.97	1.27
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	3.16	1.58	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.34	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.59	0.93	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.97	0.70	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.16	1.67	1.43
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.18	1.65	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	7.39	1.54	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.42	0.94	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.77	1.10	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.27	2.30	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.03	1.17	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.21	1.24	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.27	2.42	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.81	1.62	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.00	1.51	1.06
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.26	2.07	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	9.42	1.68	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.22	0.60	0.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.88	1.38	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.71	2.26	1.51
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.21	0.85	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	6.30	0.48	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.62	0.66	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.82	1.49	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	8.14	2.22	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.67	1.48	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.46	0.96	1.24
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.97	0.32	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	6.39	1.22	2.13
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.98	1.26	1.68
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.69	0.71	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.85	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.85	2.80	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.45	0.00	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	8.82	2.29	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.59	1.41	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	7.67	1.36	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.73	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.86	0.90	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	40.79	22.66	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.88	14.58	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	22.27	5.20	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	30.47	15.23	3.39
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	28.13	7.74	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.02	11.21	6.54
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.73	7.73	4.64
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	26.17	14.27	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	26.92	12.89	4.98
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	25.88	13.09	3.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	24.76	10.35	5.40
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	24.93	13.28	2.85
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	35.43	14.89	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	21.52	6.70	5.65
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	22.65	11.33	8.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	23.43	12.23	3.06
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	21.61	9.34	5.34
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	24.94	11.53	3.02
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	28.84	16.57	4.29
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	31.80	13.05	5.71
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	22.28	9.16	3.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	23.82	9.53	3.92
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	16.49	10.30	4.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.10	13.35	2.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	21.22	12.26	3.59
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	24.90	6.09	4.43
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	24.04	8.84	3.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	28.76	10.33	3.32
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	36.84	12.66	4.61
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	29.93	13.05	4.99
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	30.57	13.02	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	16.41	9.03	5.74
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	21.24	11.30	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	19.39	12.93	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	16.43	8.22	5.23
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	25.27	10.40	4.09
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	25.84	9.48	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	29.97	11.99	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	24.99	11.66	4.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	32.58	11.46	4.22
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	21.33	13.51	5.69
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	17.19	11.34	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	22.01	9.12	5.90
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	12.79	10.77	4.04
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	22.59	10.00	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	37.21	11.63	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	27.50	12.69	4.23
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	23.61	9.20	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.99	12.36	4.36
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	24.53	16.10	6.90
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	24.66	15.78	4.93
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	22.58	14.11	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	25.64	18.60	4.53
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	26.14	15.32	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	10.33	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	27.17	8.46	3.12
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	25.81	10.95	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	23.09	10.56	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	25.43	14.53	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	22.75	7.88	3.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	17.89	6.15	2.80
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	25.17	7.51	4.42
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	30.09	8.10	2.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.74	11.65	3.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	20.19	16.34	3.36
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	20.67	11.53	3.58
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	18.23	15.19	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	29.74	8.30	4.15
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	18.62	10.26	3.80
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	25.82	13.43	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	15.12	7.26	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	20.28	7.92	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	27.19	11.19	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	29.31	9.19	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	24.68	9.77	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	20.51	11.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	31.21	10.78	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.55	8.32	5.41
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.93	8.61	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	28.81	7.93	2.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	25.56	14.87	5.11
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	28.10	5.35	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	25.13	12.83	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	25.05	13.74	2.83
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	28.45	8.26	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	28.45	8.00	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	26.21	11.97	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	29.91	16.87	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	22.98	9.30	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	27.62	12.03	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	24.18	14.82	3.38
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	29.18	13.93	3.32
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	39.49	4.16	4.16
Macrophage - monocyte derived, donor1	11232-116C8	12.08	5.24	2.28
Macrophage - monocyte derived, donor2	11313-117C8	9.91	3.85	0.92
Macrophage - monocyte derived, donor3	11389-118C3	13.11	5.11	3.01
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	16.46	3.72	1.59
Mallassez-derived cells, donor2	11929-125I3	8.40	1.58	0.63
Mallassez-derived cells, donor3	11930-125I4	10.84	1.67	1.11
Mammary Epithelial Cell, donor1	11273-116H4	17.74	4.88	3.39
Mammary Epithelial Cell, donor2	11350-117G9	12.16	3.47	4.05
Mammary Epithelial Cell, donor3	11422-118F9	20.45	5.24	2.00
Mast cell - stimulated, donor1	11487-119E2	9.49	5.42	1.36
Mast cell, donor1	11563-120D6	22.71	8.54	3.89
Mast cell, donor2	11565-120D8	11.29	1.78	1.49
Mast cell, donor3	11566-120D9	9.46	2.48	0.45
Mast cell, donor4	11567-120E1	8.51	2.13	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	16.86	6.99	3.77
Mast cell, expanded and stimulated, donor8	11942-126A7	14.59	5.84	2.33
Mast cell, expanded, donor5	11939-126A4	26.84	7.46	4.02
Mast cell, expanded, donor8	11941-126A6	23.10	7.03	1.84
Melanocyte - dark, donor1	11502-119F8	3.38	1.09	0.90
Melanocyte - dark, donor2	11582-120F7	17.65	6.58	5.19
Melanocyte - dark, donor3	11663-122F7	26.95	8.11	5.65
Melanocyte - light, donor1	11274-116H5	11.99	4.47	3.06
Melanocyte - light, donor2	11351-117H1	21.84	8.87	6.14
Melanocyte - light, donor3	11423-118G1	23.42	6.07	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	21.55	5.83	3.44
Melanocyte, donor2 (MC+2)	12739-135I3	16.41	5.38	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	12.86	3.48	1.34
Meningeal Cells, donor1	11493-119E8	17.49	6.95	3.35
Meningeal Cells, donor2	11573-120E7	20.25	6.60	5.72
Meningeal Cells, donor3	11654-122E7	16.06	4.08	2.20
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.10	7.98	5.70
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	8.96	3.32	1.91
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	13.14	5.26	3.94
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	32.70	5.23	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	8.61	5.02	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	6.35	2.12	1.69
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	10.05	4.52	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	22.20	6.37	6.81
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	17.53	3.65	4.38
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	21.69	7.16	4.50
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	5.96	2.91	1.66
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	18.59	9.29	3.35
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	11.71	2.50	2.50
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	9.50	6.23	2.97
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	21.77	5.76	3.84
Mesenchymal stem cells - adipose, donor0	11217-116B2	15.95	3.90	3.90
Mesenchymal stem cells - hepatic, donor0	11218-116B3	13.76	3.75	2.81
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.05	5.08	6.53
Mesothelial Cells, donor1	11247-116E5	13.79	3.18	2.39
Mesothelial Cells, donor2	12156-128G5	11.01	6.51	1.00
Mesothelial Cells, donor3	11402-118D7	8.74	1.23	1.37
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	16.20	5.40	4.05
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	15.52	3.20	2.71
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	17.37	2.94	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	38.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	14.57	2.79	1.86
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.79	3.11	1.87
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	25.48	6.95	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	13.26	4.25	1.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.50	1.86	2.33
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	38.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	12.60	2.85	3.05
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	12.27	1.98	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	119.72	25.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	9.73	2.65	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	14.82	3.42	3.04
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	6.58	5.26
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.06	4.24	2.12
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	8.05	2.98	2.38
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	21.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	12.04	2.51	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	8.79	3.09	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	14.37	2.21	3.87
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.75	3.45	2.07
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.52	2.10	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	4.89	3.47	1.22
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.23	3.65	1.72
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.56	2.22	2.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.48	3.72	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.11	2.03	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	0.00	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.16	1.90	1.36
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	8.23	1.47	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	2.18	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.61	2.40	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.80	2.00	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.52	5.01	3.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	0.00	4.08
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.38	2.19	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	2.21	3.31
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.20	1.92	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	4.96	0.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	3.48	0.00	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.81	1.03	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.50	1.31	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.33	1.42	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.89	0.00	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.16	2.49	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.24	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	4.83	0.90	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4.17	2.50	2.50
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	8.31	0.92	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	3.98	1.14	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.70	1.66	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.96	2.33	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.87	3.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	9.53	3.81	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	5.60	1.60	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	6.59	4.19	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	4.38	2.12	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	6.69	3.50	2.23
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	9.95	4.42	1.55
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	5.69	1.52	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	7.39	2.56	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	12.04	3.69	2.46
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.99	3.26	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.00	3.82	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	7.78	6.92	2.59
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	8.24	2.47	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	8.64	4.17	2.08
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	3.77	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	30.30	8.91	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	10.51	2.96	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	14.73	4.21	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	13.24	5.54	2.37
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	14.90	1.86	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	13.52	4.13	4.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.85	4.00	3.20
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	8.93	4.30	2.15
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.05	8.10	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	5.86	4.76	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	4.67	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	17.64	3.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	13.13	4.04	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.90	4.64	2.11
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	9.53	4.09	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	20.35	6.99	4.45
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	25.10	13.77	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	6.04	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	0.00	17.13
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	9.69	3.66	2.59
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	12.02	3.14	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.67	0.67	2.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.43	4.59	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	12.93	3.04	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	27.13	12.77	4.79
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.16	2.72	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.95	1.67	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	14.88	3.72	2.56
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.65	2.43	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	9.46	3.36	2.10
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.45	1.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	6.50	2.71	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	3.85	1.81	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	5.06	2.45	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	7.29	2.19	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.37	1.59	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	5.40	1.20	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	5.25	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.34	2.44	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	6.35	2.12	1.76
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	8.44	2.81	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	4.60	0.92	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.64	1.61	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	5.17	2.07	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	2.53	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	5.35	2.23	1.78
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.08	1.69	1.69
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.97	2.61	1.90
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	8.16	1.29	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	5.33	1.00	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	5.41	1.35	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	2.78	2.38	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	0.93	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	10.59	3.03	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	7.50	2.28	2.28
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	5.67	2.18	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	8.14	3.62	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	3.53	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	2.66	3.32	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	3.47	2.48	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.51	3.83	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.70	3.93	1.81
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	6.63	3.54	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.71	2.71	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.93	1.22	4.27
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.87	2.52	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	7.57	2.12	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	6.33	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	13.60	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	7.21	2.24	0.87
Myoblast, donor2	11322-117D8	8.25	1.92	1.92
Myoblast, donor3	11398-118D3	11.10	4.20	2.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	64.06	14.01	7.73
Natural Killer Cells, donor1	11230-116C6	8.92	4.31	2.15
Natural Killer Cells, donor2	11311-117C6	11.76	3.92	0.00
Natural Killer Cells, donor3	11387-118C1	12.70	2.76	0.55
Neural stem cells, donor1	11275-116H6	21.78	6.53	2.90
Neural stem cells, donor2	11352-117H2	7.70	1.93	0.00
Neurons, donor1	11494-119E9	22.76	2.28	2.28
Neurons, donor2	11574-120E8	20.92	3.74	1.98
Neurons, donor3	11655-122E8	18.91	6.58	0.82
Neutrophils, donor1	11233-116C9	1.86	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	6.06	3.21	1.31
Nucleus Pulposus Cell, donor2	11409-118E5	13.35	8.79	3.58
Nucleus Pulposus Cell, donor3	11462-119B4	18.25	6.02	3.21
Olfactory epithelial cells, donor1	11933-125I7	7.85	4.96	1.65
Olfactory epithelial cells, donor2	11934-125I8	6.95	3.91	2.61
Olfactory epithelial cells, donor3	11935-125I9	10.22	4.31	1.59
Olfactory epithelial cells, donor4	11936-126A1	9.45	3.41	1.46
Oligodendrocyte - precursors, donor1	11496-119F2	18.05	3.61	3.61
Osteoblast - differentiated, donor1	11276-116H7	11.27	5.74	2.55
Osteoblast - differentiated, donor2	11353-117H3	28.58	6.86	8.00
Osteoblast - differentiated, donor3	11425-118G3	22.35	8.07	4.97
Osteoblast, donor1	11277-116H8	22.28	8.21	4.10
Osteoblast, donor2	11354-117H4	8.43	3.51	0.70
Osteoblast, donor3	11426-118G4	19.91	7.82	4.09
Pancreatic stromal cells, donor1	11249-116E7	9.43	3.87	2.95
Pericytes, donor1	11491-119E6	18.92	7.68	4.45
Pericytes, donor2	11571-120E5	13.81	7.02	3.17
Pericytes, donor3	11652-122E5	14.65	2.24	2.24
Perineurial Cells, donor1	11499-119F5	9.15	2.15	2.60
Perineurial Cells, donor2	11579-120F4	17.11	7.08	2.21
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	8.29	2.87	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	8.08	2.69	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	8.54	2.33	1.94
Placental Epithelial Cells, donor1	11278-116H9	38.74	6.22	5.26
Placental Epithelial Cells, donor2	11355-117H5	32.16	6.65	5.54
Placental Epithelial Cells, donor3	11427-118G5	21.99	5.30	4.12
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	10.13	2.53	1.90
Preadipocyte - breast, donor1	11467-119B9	6.19	2.63	2.06
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	3.52	0.91	0.39
Preadipocyte - breast, donor2	11328-117E5	9.01	3.15	2.03
Preadipocyte - omental, donor1	11468-119C1	7.46	2.98	2.02
Preadipocyte - omental, donor2	11329-117E6	13.53	3.49	1.75
Preadipocyte - omental, donor3	11403-118D8	10.31	4.15	1.29
Preadipocyte - perirenal, donor1	11469-119C2	17.72	3.94	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	17.51	10.44	4.91
Preadipocyte - subcutaneous, donor2	11356-117H6	15.05	4.60	3.19
Preadipocyte - subcutaneous, donor3	11428-118G6	16.52	6.98	4.77
Preadipocyte - visceral, donor1	11280-116I2	13.79	4.66	4.01
Preadipocyte - visceral, donor2	11357-117H7	11.04	2.76	0.46
Preadipocyte - visceral, donor3	11429-118G7	16.82	4.49	3.24
Prostate Epithelial Cells (polarized), donor1	11253-116F2	18.40	6.49	2.11
Prostate Epithelial Cells, donor2	11331-117E8	5.15	1.22	1.49
Prostate Epithelial Cells, donor3	11404-118D9	6.43	0.80	0.24
Prostate Stromal Cells, donor1	11254-116F3	14.01	4.78	3.64
Prostate Stromal Cells, donor2	11332-117E9	23.13	6.45	2.33
Prostate Stromal Cells, donor3	11405-118E1	11.05	4.28	1.77
Renal Cortical Epithelial Cells, donor1	11516-119H4	27.01	4.38	4.74
Renal Cortical Epithelial Cells, donor2	11596-120H3	14.42	1.39	2.15
Renal Epithelial Cells, donor1	11517-119H5	26.38	8.12	3.55
Renal Epithelial Cells, donor2	11597-120H4	27.03	4.27	4.98
Renal Epithelial Cells, donor3	11678-122H4	15.24	2.01	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	17.70	3.40	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	13.34	3.37	2.56
Renal Glomerular Endothelial Cells, donor3	11675-122H1	16.21	3.11	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.31	1.33	2.00
Renal Mesangial Cells, donor1	11518-119H6	19.81	5.06	3.52
Renal Mesangial Cells, donor2	11598-120H5	33.23	6.27	4.39
Renal Mesangial Cells, donor3	11679-122H5	21.08	6.66	3.33
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	19.86	4.83	4.03
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	37.95	3.80	3.37
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	26.03	5.79	3.47
Retinal Pigment Epithelial Cells, donor0	11215-116A9	17.11	3.11	2.07
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.35	5.12	4.55
Retinal Pigment Epithelial Cells, donor2	11608-120I6	24.70	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.33	3.76	1.76
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	34.75	9.76	5.35
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	8.04	6.25	4.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	2.20	0.55	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	6.96	1.74	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	10.66	4.29	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	13.11	5.06	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	15.50	5.80	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	9.06	4.71	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	12.47	4.55	2.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	14.33	5.78	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	9.72	3.29	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	12.25	4.08	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	19.17	10.39	3.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	10.33	3.87	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	10.62	3.33	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	16.60	4.65	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	8.99	3.06	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	13.42	4.75	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	12.03	6.01	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	11.01	3.45	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	10.71	4.28	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	13.75	6.87	2.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	8.44	3.31	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	12.33	5.05	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	11.62	5.47	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	12.76	3.83	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	11.04	4.05	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	12.76	4.84	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	8.26	3.54	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	13.69	4.56	2.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	13.33	5.61	3.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	8.50	3.53	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	15.71	3.76	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	12.53	3.55	3.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	8.48	4.71	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	12.26	3.58	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	12.92	5.59	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	7.05	3.27	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	13.17	4.80	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	13.13	3.28	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	7.16	2.22	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	13.76	5.47	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	8.00	3.20	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	9.40	4.15	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	15.95	6.19	2.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	12.90	3.43	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	11.11	4.80	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	15.02	3.49	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	14.51	6.35	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	9.55	3.92	1.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	14.56	8.59	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	20.69	5.48	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	12.06	5.12	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	12.67	4.30	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	19.77	3.00	3.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	10.63	6.61	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	15.79	4.70	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	17.43	6.01	1.80
Schwann Cells, donor1	11498-119F4	36.86	10.53	7.33
Schwann Cells, donor2	11578-120F3	23.82	10.21	6.80
Schwann Cells, donor3	11659-122F3	18.62	5.92	3.94
Sebocyte, donor1	11220-116B5	7.12	3.83	1.64
Sebocyte, donor2	11301-117B5	11.95	2.76	1.84
Sebocyte, donor3	11378-118B1	8.86	3.09	2.47
Sertoli Cells, donor1	11255-116F4	14.91	6.63	4.97
Sertoli Cells, donor2	11333-117F1	11.30	5.65	2.82
Skeletal Muscle Cells, donor1	11281-116I3	16.10	4.22	2.38
Skeletal Muscle Cells, donor2	11358-117H8	14.46	7.95	1.45
Skeletal Muscle Cells, donor3	11430-118G8	29.26	15.88	5.85
Skeletal Muscle Cells, donor4	11451-119A2	19.95	8.33	4.71
Skeletal Muscle Cells, donor5	11455-119A6	21.11	6.84	3.86
Skeletal Muscle Cells, donor6	11459-119B1	26.32	4.31	3.54
Skeletal Muscle Satellite Cells, donor1	11240-116D7	22.93	7.06	3.65
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.26	5.28	3.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	19.35	4.07	4.37
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	10.19	2.95	3.03
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	32.57	11.58	7.24
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	19.26	7.57	4.82
Skin - palm, donor1	10286-104F7	34.92	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.92	1.15	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	2.45	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.49	2.08	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	8.06	1.53	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	10.13	1.69	1.13
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	6.34	0.85	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	7.64	0.52	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.57	3.39	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	2.89	1.11	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	13.52	1.76	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	10.61	2.43	1.77
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.60	3.54	3.94
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.82	3.86	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	15.01	5.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.25	1.86	2.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	13.30	3.55	3.77
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	18.56	4.48	3.71
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.65	6.84	2.28
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	16.54	5.61	4.73
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.10	3.13	1.99
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	14.48	5.04	3.74
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.92	2.74	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	15.15	7.32	5.05
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	13.35	4.29	3.34
Smooth Muscle Cells - Colonic, donor1	11239-116D6	11.95	4.57	2.95
Smooth Muscle Cells - Colonic, donor2	11320-117D6	15.07	5.38	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.74	5.14	2.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	10.67	4.18	1.86
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	3.23	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.85	4.18	2.69
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	18.44	5.46	3.41
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	9.42	2.98	1.49
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	5.33	2.42	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	12.97	5.69	2.05
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.08	4.23	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	16.69	4.50	3.18
Smooth Muscle Cells - Prostate, donor1	11257-116F6	13.72	7.59	3.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.02	3.76	2.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.85	3.55	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	11.61	3.17	3.32
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.75	5.25	4.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	9.05	2.58	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.02	5.12	2.79
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	11.61	2.02	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	12.85	4.07	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.67	3.83	1.77
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	17.83	6.16	3.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.01	2.34	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.51	2.01	2.16
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	14.02	5.86	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	18.99	6.21	3.20
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	13.42	4.33	2.24
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	12.90	2.51	2.01
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.00	3.33	1.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.03	3.67	1.71
Smooth Muscle Cells - Uterine, donor1	11258-116F7	8.84	1.99	1.77
Smooth Muscle Cells - Uterine, donor3	11466-119B8	19.60	4.10	4.10
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	4.08	2.72	1.94
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	6.61	1.06	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2.60	2.23	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	6.11	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.08	3.41	2.27
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	8.27	4.73	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	5.59	2.03	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	5.59	2.40	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	6.27	5.85	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	8.71	3.21	2.29
Synoviocyte, donor1	11291-117A4	11.11	2.69	2.36
Synoviocyte, donor2	11368-117I9	14.92	5.36	2.35
Synoviocyte, donor3	11440-118H9	13.18	5.14	1.79
Trabecular Meshwork Cells, donor1	11532-120A2	15.72	5.72	6.07
Trabecular Meshwork Cells, donor2	11612-122A1	47.57	9.91	11.89
Trabecular Meshwork Cells, donor3	11693-123A1	26.63	6.02	5.56
Tracheal Epithelial Cells, donor1	11292-117A5	19.00	2.37	2.72
Tracheal Epithelial Cells, donor2	11369-118A1	18.17	5.41	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	20.62	4.58	4.58
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	36.91	11.07	5.91
Urethra, donor2	10319-105A4	17.98	1.80	3.60
Urothelial Cells, donor1	11520-119H8	9.30	2.39	1.33
Urothelial Cells, donor2	11600-120H7	11.62	0.40	0.40
Urothelial Cells, donor3	11681-122H7	11.23	1.15	0.69
Urothelial cells, donor0	11216-116B1	9.81	1.11	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	10.68	5.34	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	8.58	5.72	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	4.79	1.37	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	9.99	2.75	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	13.36	4.65	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	7.29	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	7.34	3.67	4.59
Whole blood (ribopure), donor090612, donation3	12184-129A6	11.87	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	23.81	9.75	3.70
Wilms' tumor cell line:HFWT	10597-108E3	21.12	2.64	7.04
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	23.46	3.91	2.79
achilles tendon, donor2	10292-104G4	10.33	0.00	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	26.77	8.41	3.06
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	24.15	8.82	3.02
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	38.46	9.62	3.68
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	40.54	13.88	7.07
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	21.36	8.43	3.37
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	43.14	26.01	10.15
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	13.34	5.72	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	21.15	4.85	4.85
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	16.74	2.45	4.08
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	29.12	8.54	7.38
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	10.67	3.86	2.02
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	11.70	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	30.91	8.37	5.58
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	27.70	6.21	4.92
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	17.53	6.14	4.38
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	39.50	13.01	4.65
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	30.43	4.52	3.29
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	25.78	7.37	3.68
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	25.18	7.68	5.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	23.66	7.58	4.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	26.96	8.18	3.37
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	21.38	8.24	4.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	49.70	16.34	10.01
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	59.46	16.72	7.43
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	38.42	10.55	9.04
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	18.32	9.16	3.93
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	54.36	15.00	15.00
adenocarcinoma cell line:IM95m	10796-110I4	41.92	12.95	6.59
adipose tissue, adult, pool1	10010-101C1	15.67	5.12	2.79
adipose, donor1	10184-103D4	43.39	3.52	2.35
adipose, donor2	10185-103D5	19.46	4.06	1.22
adipose, donor3	10186-103D6	25.87	3.54	1.91
adipose, donor4	10187-103D7	21.67	5.20	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	26.83	2.84	3.00
adrenal gland, adult, pool1	10081-102A9	29.10	29.10	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	30.15	7.47	4.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	23.94	6.43	3.93
amniotic membrane cells, donor1	12235-129G3	16.46	3.01	1.62
amniotic membrane cells, donor2	12236-129G4	18.93	6.09	2.03
amniotic membrane cells, donor3	12237-129G5	17.09	3.83	0.88
amygdala - adult, donor10196	10167-103B5	4.74	3.56	1.19
amygdala, adult, donor10252	10151-102I7	11.96	4.87	1.82
amygdala, newborn, donor10223	10360-105E9	6.46	0.65	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	13.11	2.55	2.04
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	24.93	6.18	2.87
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	23.72	3.34	3.01
aorta, adult, pool1	10052-101G7	17.85	3.73	2.94
appendix, adult	10189-103D9	25.23	5.43	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	24.08	6.53	0.69
artery, adult	10190-103E1	80.16	6.79	1.36
astrocytoma cell line:TM-31	10425-106D2	14.78	5.79	2.46
b cell line:RPMI1788	10427-106D4	15.76	2.23	2.08
basal cell carcinoma cell line:TE 354.T	10702-109G9	7.77	1.66	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	22.23	6.05	2.98
bile duct carcinoma cell line:TFK-1	10496-107C1	27.45	8.20	3.18
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	45.30	8.39	3.91
bladder, adult, pool1	10011-101C2	12.71	2.61	1.52
blood, adult, pool1	10053-101G8	13.29	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.99	7.71	0.86
bone marrow, adult	10192-103E3	30.37	7.42	2.02
brain, adult, donor1	10084-102B3	18.45	1.03	2.05
brain, adult, pool1	10012-101C3	11.47	4.45	3.23
brain, fetal, pool1	10085-102B4	24.04	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	17.51	3.30	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	34.45	9.24	5.74
breast, adult, donor1	10080-102A8	15.78	2.53	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	23.50	8.89	6.35
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	27.83	8.66	4.33
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	13.12	3.91	2.53
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	9.20	4.12	1.21
carcinoid cell line:NCI-H1770	10703-109H1	74.29	13.16	6.58
carcinoid cell line:NCI-H727	10735-110B6	57.10	13.13	7.44
carcinoid cell line:SK-PN-DW	10719-109I8	22.50	7.61	3.80
carcinosarcoma cell line:JHUCS-1	10642-109A3	47.38	13.58	2.66
caudate nucleus - adult, donor10196	10177-103C6	13.82	4.61	2.30
caudate nucleus, adult, donor10252	10164-103B2	13.39	4.85	2.01
caudate nucleus, adult, donor10258	10379-105H1	16.05	6.88	0.76
caudate nucleus, newborn, donor10223	10354-105E3	6.59	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	8.74	2.91	2.91
cerebellum, adult, donor10252	10166-103B4	6.41	2.56	1.07
cerebellum, adult, pool1	10083-102B2	19.66	5.17	4.48
cerebellum, newborn, donor10223	10357-105E6	6.64	1.66	1.66
cerebral meninges, adult	10188-103D8	23.95	10.84	4.29
cerebrospinal fluid, donor2	10294-104G6	34.35	5.12	0.73
cervical cancer cell line:D98-AH2	10552-107I3	56.51	6.76	5.90
cervical cancer cell line:ME-180	10553-107I4	40.77	13.09	5.47
cervix, adult, pool1	10013-101C4	11.13	3.78	1.47
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	19.65	4.46	2.51
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	3.92	5.23
choriocarcinoma cell line:BeWo	10423-106C9	16.65	2.73	1.62
choriocarcinoma cell line:SCH	10785-110H2	44.11	8.38	2.96
choriocarcinoma cell line:T3M-3	10618-108G6	20.87	3.56	1.90
chorionic membrane cells, donor1	12238-129G6	14.82	2.85	0.57
chorionic membrane cells, donor2	12239-129G7	17.10	5.57	2.88
chorionic membrane cells, donor3	12240-129G8	13.19	6.59	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	64.63	23.23	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	10.95	1.92	2.31
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	15.63	4.43	2.53
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	9.50	1.54	2.05
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	10.40	3.14	1.94
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	7.33	3.87	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	18.85	3.53	2.94
chronic myelogenous leukemia cell line:KU812	10409-106B4	9.64	2.87	2.09
clear cell carcinoma cell line:JHOC-5	10638-108I8	12.11	3.20	2.06
clear cell carcinoma cell line:TEN	10636-108I6	11.97	2.95	0.87
colon carcinoma cell line:CACO-2	10513-107D9	33.50	12.26	4.39
colon carcinoma cell line:COLO-320	10420-106C6	16.72	3.80	3.04
colon, adult, donor1	10082-102B1	23.80	7.14	5.95
colon, adult, pool1	10014-101C5	22.33	6.35	3.17
colon, fetal, donor1	10070-101I7	16.07	3.09	0.62
common myeloid progenitor CMP, donor1	12130-128D6	64.17	4.58	18.33
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	25.07	11.90	5.52
cord blood derived cell line:COBL-a 24h infection	10453-106G3	28.83	16.60	4.98
cord blood derived cell line:COBL-a untreated	10449-106F8	26.79	17.34	5.64
corpus callosum, adult, pool1	10042-101F6	16.47	7.63	2.76
cruciate ligament, donor2	10295-104G7	20.26	3.24	4.05
diaphragm, fetal, donor1	10069-101I6	36.92	0.00	0.80
diencephalon, adult	10193-103E4	18.48	5.52	4.08
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	30.54	6.66	5.28
ductal cell carcinoma cell line:KLM-1	10438-106E6	52.83	15.39	9.23
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	25.76	5.78	3.61
ductus deferens, adult	10196-103E7	27.91	12.46	8.47
duodenum, fetal, donor1, tech_rep1	10071-101I8	12.96	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	11.77	5.89	2.21
dura mater, adult, donor1	10041-101F5	15.44	2.89	2.73
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	25.76	9.99	3.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	24.36	6.30	4.30
embryonic pancreas cell line:1B2C6	10604-108F1	23.43	4.32	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	13.32	3.94	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	13.89	2.78	1.23
embryonic pancreas cell line:2C6	10603-108E9	21.02	2.63	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	12.07	5.03	2.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	23.92	6.34	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	18.82	4.18	4.82
epidermoid carcinoma cell line:A431	10426-106D3	16.12	2.56	1.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	12.32	3.08	1.65
epididymis, adult	10197-103E8	27.84	7.74	4.60
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	6.74	1.42	2.66
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.19	0.79	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	20.18	6.95	3.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	18.21	6.59	3.35
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	21.51	8.51	4.37
esophagus, adult, pool1	10015-101C6	15.08	3.50	1.49
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	15.53	4.01	2.38
eye - muscle inferior rectus, donor1	10272-104E2	36.22	4.83	4.83
eye - muscle lateral, donor2	10298-104H1	92.58	6.31	6.31
eye - muscle medial, donor2	10299-104H2	74.41	10.42	4.46
eye - muscle superior, donor2	10297-104G9	45.86	6.88	1.15
eye - vitreous humor, donor1	10268-104D7	34.98	7.29	2.91
eye, fetal, donor1	10054-101G9	17.29	5.59	3.05
fibrosarcoma cell line:HT-1080	10758-110E2	12.44	6.41	2.05
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	25.88	4.51	1.90
frontal lobe, adult, pool1	10040-101F4	12.85	5.07	2.72
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	29.12	11.71	5.40
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	9.69	1.10	1.10
gall bladder, adult	10198-103E9	26.80	7.24	3.86
gamma delta positive T cells, donor1	11937-126A2	15.57	8.59	3.22
gamma delta positive T cells, donor2	11938-126A3	21.29	8.96	3.36
gastric adenocarcinoma cell line:MKN1	10614-108G2	28.09	8.24	5.70
gastric adenocarcinoma cell line:MKN45	10612-108F9	18.37	5.22	4.45
gastric cancer cell line:AZ521	10549-107H9	39.51	10.98	6.39
gastric cancer cell line:GSS	10560-108A2	21.97	0.92	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	39.75	7.77	4.34
giant cell carcinoma cell line:LU65	10487-107B1	11.93	1.61	1.61
giant cell carcinoma cell line:Lu99B	10433-106E1	13.44	2.24	1.82
glassy cell carcinoma cell line:HOKUG	10688-109F4	25.19	9.98	3.49
glioblastoma cell line:A172, tech_rep1	10444-106F3	11.93	4.75	3.59
glioblastoma cell line:A172, tech_rep2	10444-106F3	12.78	4.07	3.37
glioblastoma cell line:T98G	10485-107A8	27.15	7.62	6.18
glioma cell line:GI-1	10413-106B8	13.47	3.81	2.64
globus pallidus - adult, donor10196	10175-103C4	9.48	4.37	3.64
globus pallidus, adult, donor10252	10161-103A8	15.62	7.57	2.44
globus pallidus, adult, donor10258	10367-105F7	24.65	6.85	1.37
globus pallidus, newborn, donor10223	10364-105F4	9.06	2.66	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	51.39	9.79	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	67.95	31.36	5.23
granulosa cell tumor cell line:KGN	10624-108H3	11.52	4.80	2.88
hIPS +CCl2, biol_rep1	14383-156B9	9.18	0.92	1.84
hIPS +CCl2, biol_rep2	14384-156C1	9.15	0.91	0.46
hIPS +CCl2, biol_rep3	14385-156C2	7.09	2.58	0.00
hIPS, biol_rep1	14380-156B6	4.31	0.00	1.44
hIPS, biol_rep2	14381-156B7	5.49	0.69	2.06
hIPS, biol_rep3	14382-156B8	9.93	9.93	4.41
hairy cell leukemia cell line:Mo	10712-109I1	27.01	10.06	4.02
heart - mitral valve, adult	10205-103F7	15.25	5.08	2.69
heart - pulmonic valve, adult	10206-103F8	35.82	7.32	2.88
heart - tricuspid valve, adult	10207-103F9	16.65	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	32.85	4.49	3.47
heart, adult, diseased, donor1	10051-101G6	45.99	6.81	2.55
heart, adult, pool1	10016-101C7	43.01	10.35	3.68
heart, fetal, pool1	10046-101G1	17.97	4.62	2.36
hepatic mesenchymal tumor cell line:LI90	10778-110G4	7.10	2.47	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	30.92	4.76	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	20.22	5.86	2.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	24.52	5.95	1.94
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	22.23	5.46	3.13
hepatoma cell line:Li-7	10484-107A7	34.59	6.23	4.34
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	28.14	7.24	2.81
hippocampus - adult, donor10196	10169-103B7	5.68	2.84	0.95
hippocampus, adult, donor10252	10153-102I9	11.84	3.27	2.25
hippocampus, adult, donor10258	10374-105G5	10.46	1.49	2.49
hippocampus, newborn, donor10223	10363-105F3	5.99	2.47	2.47
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	34.79	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	19.44	1.77	2.16
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	18.53	2.54	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	29.32	1.69	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	29.95	1.81	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	35.68	3.04	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	26.86	3.80	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	22.62	4.74	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	22.52	2.92	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	34.81	6.39	4.03
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	28.13	4.82	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	26.26	5.39	6.73
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	18.15	3.44	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	20.14	1.47	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	14.84	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	28.25	2.29	2.29
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	26.16	1.74	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	34.48	2.00	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	20.35	1.88	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	18.64	2.27	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	23.49	2.19	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	25.96	4.57	1.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	27.87	3.77	2.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	29.89	5.98	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	21.43	2.59	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	21.40	3.42	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	25.72	2.86	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	22.18	2.46	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	23.44	4.43	3.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	34.80	1.82	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	20.17	4.65	3.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	24.57	5.31	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	30.53	5.13	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	25.31	5.37	3.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	26.50	4.54	4.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	25.20	7.39	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	19.80	2.42	2.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	24.51	2.67	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	30.24	5.37	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	30.26	3.36	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	26.03	6.51	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	37.40	2.98	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	26.27	5.47	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	35.10	1.09	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	26.33	2.85	2.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	26.25	1.19	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	27.76	6.23	3.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	28.83	5.12	2.42
immature langerhans cells, donor1	11904-125F5	6.78	0.97	1.21
immature langerhans cells, donor2	11905-125F6	11.09	2.38	3.17
insula, adult, pool1	10039-101F3	14.01	3.79	3.88
keratoacanthoma cell line:HKA-1	10791-110H8	40.64	17.88	7.15
kidney, adult, pool1	10017-101C8	29.64	13.62	5.21
kidney, fetal, pool1	10045-101F9	19.95	5.52	2.62
large cell lung carcinoma cell line:IA-LM	10509-107D5	9.09	2.98	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	13.13	4.42	1.80
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	41.10	4.77	2.75
left atrium, adult, donor1	10079-102A7	28.88	6.54	3.27
left ventricle, adult, donor1	10078-102A6	43.99	1.52	2.02
leiomyoblastoma cell line:G-402	10721-110A1	13.13	1.92	1.09
leiomyoma cell line:10964C	10569-108B2	11.50	3.95	2.16
leiomyoma cell line:15242A	10570-108B3	3.80	2.72	0.00
leiomyoma cell line:15425	10571-108B4	8.98	2.67	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	15.68	3.14	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	11.57	4.84	2.36
liposarcoma cell line:KMLS-1	10782-110G8	4.53	2.66	0.16
liposarcoma cell line:SW 872	10726-110A6	25.59	11.82	5.24
liver, adult, pool1	10018-101C9	67.09	17.02	9.24
liver, fetal, pool1	10086-102B5	50.80	4.70	4.70
locus coeruleus - adult, donor10196	10182-103D2	10.50	4.52	2.19
locus coeruleus, adult, donor10252	10165-103B3	11.81	5.17	2.03
locus coeruleus, adult, donor10258	10375-105G6	18.90	6.21	3.95
locus coeruleus, newborn, donor10223	10362-105F2	5.47	1.26	0.00
lung adenocarcinoma cell line:A549	10499-107C4	39.03	15.64	6.23
lung adenocarcinoma cell line:PC-14	10408-106B3	18.61	0.69	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	33.61	9.49	4.22
lung, adult, pool1	10019-101D1	14.06	4.37	1.65
lung, fetal, donor1	10068-101I5	8.85	1.71	0.86
lung, right lower lobe, adult, donor1	10075-102A3	26.12	4.58	1.37
lymph node, adult, donor1	10077-102A5	14.67	3.31	1.42
lymphangiectasia cell line:DS-1	10727-110A7	19.51	3.73	2.19
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	22.94	8.90	3.77
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	8.49	2.55	0.00
mature adipocyte, donor1	12231-129F8	83.03	22.20	10.21
mature adipocyte, donor2	12232-129F9	67.45	15.98	11.21
mature adipocyte, donor3	12233-129G1	61.40	20.86	9.01
mature adipocyte, donor4	12234-129G2	60.01	15.79	5.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	13.10	2.86	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	10.15	6.77	5.64
medial frontal gyrus, adult, donor10252	10150-102I6	7.91	3.86	3.49
medial frontal gyrus, adult, donor10258	10368-105F8	12.39	7.62	4.13
medial frontal gyrus, newborn, donor10223	10352-105E1	5.12	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	10.29	4.56	4.39
medial temporal gyrus, adult, donor10252	10156-103A3	10.40	3.18	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	5.78	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	6.46	1.08	1.08
medulla oblongata - adult, donor10196	10174-103C3	8.44	3.24	1.30
medulla oblongata, adult, donor10252	10155-103A2	13.00	4.80	2.32
medulla oblongata, adult, pool1	10038-101F2	15.84	6.61	3.18
medulla oblongata, newborn, donor10223	10361-105F1	10.76	2.43	2.43
medulloblastoma cell line:D283 Med	10838-111E1	14.83	2.21	0.66
medulloblastoma cell line:ONS-76	10759-110E3	33.38	7.58	5.26
melanoma cell line:COLO 679	10514-107E1	13.22	5.89	4.17
melanoma cell line:G-361	10465-106H6	11.94	2.99	2.44
meningioma cell line:HKBMM	10691-109F7	17.19	1.27	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	52.87	14.10	7.05
merkel cell carcinoma cell line:MS-1	10844-111E7	51.59	19.18	11.15
mesenchymal precursor cell - adipose, donor1	11747-123G1	20.87	9.21	3.53
mesenchymal precursor cell - adipose, donor2	11748-123G2	13.82	4.36	1.82
mesenchymal precursor cell - adipose, donor3	11749-123G3	11.18	3.73	5.80
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	5.90	3.23	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	12.32	2.70	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.02	5.55	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	19.91	4.29	3.26
mesenchymal precursor cell - cardiac, donor2	11753-123G7	8.97	2.65	1.84
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.05	6.63	3.32
mesenchymal precursor cell - cardiac, donor4	11755-123G9	15.80	3.24	2.97
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	6.97	2.13	1.99
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	8.56	3.95	2.31
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	12.18	4.57	1.94
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	12.92	5.59	2.44
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	6.53	1.63	1.84
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.91	1.44	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.76	2.59	1.24
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	4.79	1.37	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	11.33	1.68	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	10.01	2.69	1.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	10.42	2.98	2.28
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	7.73	3.68	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	6.87	2.00	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.89	6.32	4.21
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	12.79	5.02	4.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	10.23	3.58	2.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	14.13	3.93	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.32	4.31	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	13.42	4.24	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	12.52	2.37	3.38
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	11.79	2.75	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	13.44	3.71	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	9.52	4.04	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	11.38	4.02	3.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	8.41	3.85	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.93	7.33	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.41	5.03	2.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	10.64	4.50	3.28
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.45	6.44	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	15.91	2.92	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	5.82	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.72	4.26	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.99	1.64	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.05	3.50	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	11.86	5.34	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	13.40	2.44	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	15.83	2.53	4.43
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	14.49	7.24	3.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	6.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	12.63	4.48	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	20.66	3.97	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	18.28	4.72	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	14.34	2.81	2.81
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	9.36	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	2.37	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.72	6.20	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	99.95	5.94	8.41
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	70.65	3.36	8.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	86.50	14.63	7.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	185.37	28.21	22.57
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	196.25	34.89	28.35
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	163.45	22.81	12.67
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	131.69	17.60	12.74
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	203.35	18.08	18.08
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	160.62	21.42	21.42
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	39.88	8.53	6.94
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	34.40	4.87	2.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	38.71	6.11	6.11
mesodermal tumor cell line:HIRS-BM	10696-109G3	16.25	1.55	4.64
mesothelioma cell line:ACC-MESO-1	10493-107B7	12.28	2.36	1.89
mesothelioma cell line:ACC-MESO-4	10494-107B8	20.16	4.17	2.55
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	18.08	5.65	2.16
mesothelioma cell line:Mero-25	10850-111F4	16.11	2.27	2.50
mesothelioma cell line:Mero-41	10851-111F5	24.69	4.40	2.44
mesothelioma cell line:Mero-48a	10852-111F6	37.64	8.64	6.86
mesothelioma cell line:Mero-82	10853-111F7	18.66	5.78	3.42
mesothelioma cell line:Mero-83	10854-111F8	11.75	5.62	1.70
mesothelioma cell line:Mero-84	10855-111F9	17.44	3.29	1.77
mesothelioma cell line:Mero-95	10856-111G1	16.36	3.93	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	20.37	5.30	2.65
mesothelioma cell line:NCI-H226	10846-111E9	7.24	2.17	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	16.23	4.44	3.59
mesothelioma cell line:NCI-H28	10845-111E8	9.67	2.29	2.80
mesothelioma cell line:No36	10857-111G2	38.82	10.44	7.50
mesothelioma cell line:ONE58	10858-111G3	9.48	1.63	2.44
migratory langerhans cells, donor1	11901-125F2	8.64	0.77	1.15
migratory langerhans cells, donor2	11902-125F3	12.21	1.83	1.83
migratory langerhans cells, donor3	11903-125F4	25.31	4.31	3.59
mixed mullerian tumor cell line:HTMMT	10689-109F5	45.71	4.24	3.59
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	6.78	6.15	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	22.11	4.84	2.99
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	22.26	6.66	3.81
myelodysplastic syndrome cell line:SKM-1	10772-110F7	46.20	12.20	7.02
myeloma cell line:PCM6	10474-106I6	142.91	40.52	16.21
myxofibrosarcoma cell line:MFH-ino	10600-108E6	21.81	12.68	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	10.40	6.86	3.14
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.49	1.78	1.23
nasal epithelial cells, donor1, tech_rep2	12226-129F3	17.21	1.40	1.25
nasal epithelial cells, donor2	12227-129F4	11.59	4.42	1.10
neuroblastoma cell line:CHP-134	10508-107D4	48.77	19.33	10.12
neuroblastoma cell line:NB-1	10539-107G8	14.97	6.55	3.93
neuroblastoma cell line:NBsusSR	10607-108F4	34.59	4.01	5.06
neuroblastoma cell line:NH-12	10555-107I6	19.01	4.29	3.17
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	13.28	1.19	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	33.42	5.54	2.85
neuroectodermal tumor cell line:TASK1	10774-110F9	36.03	7.45	4.03
neuroepithelioma cell line:SK-N-MC	10728-110A8	28.61	3.81	3.18
neurofibroma cell line:Hs 53.T	10729-110A9	13.31	2.66	2.66
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	19.11	4.23	1.69
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	52.83	28.82	15.21
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	20.84	4.49	2.56
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	27.06	7.62	1.84
nucleus accumbens, adult, pool1	10037-101F1	13.22	6.47	2.62
occipital cortex - adult, donor10196	10172-103C1	8.24	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	13.69	6.71	1.61
occipital cortex, newborn, donor10223	10355-105E4	4.37	1.46	1.09
occipital lobe, adult, donor1	10076-102A4	15.48	6.82	2.62
occipital lobe, fetal, donor1	10073-102A1	9.87	0.86	0.86
occipital pole, adult, pool1	10036-101E9	15.37	5.99	2.84
olfactory region, adult	10195-103E6	17.96	3.25	3.25
optic nerve, donor1	10277-104E7	12.01	4.00	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	13.56	5.92	2.73
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	17.31	3.57	1.37
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	10.67	3.22	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	22.99	7.97	4.39
osteoclastoma cell line:Hs 706.T	10704-109H2	17.93	5.00	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	54.19	5.61	6.54
osteosarcoma cell line:HS-Os-1	10558-107I9	7.00	1.70	1.27
ovary, adult, pool1	10020-101D2	6.90	2.97	0.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	8.98	1.10	0.55
pancreas, adult, donor1	10049-101G4	37.63	4.70	6.58
pancreatic carcinoma cell line:NOR-P1	10698-109G5	18.73	1.12	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	37.82	5.62	3.24
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	23.02	4.31	1.49
paracentral gyrus, adult, pool1	10035-101E8	13.91	7.23	4.21
parietal cortex, adult, donor10258	10373-105G4	9.54	0.73	1.47
parietal lobe - adult, donor10196	10171-103B9	16.93	4.70	0.94
parietal lobe, adult, donor10252	10157-103A4	9.69	3.14	2.28
parietal lobe, adult, pool1	10034-101E7	11.46	6.61	3.97
parietal lobe, fetal, donor1	10072-101I9	10.67	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	6.36	0.37	0.37
parotid gland, adult	10199-103F1	25.90	3.70	4.32
penis, adult	10200-103F2	29.54	2.15	4.30
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	5.95	0.74	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	11.51	2.19	1.31
pineal gland - adult, donor10196	10179-103C8	8.39	6.45	0.65
pineal gland, adult, donor10252	10160-103A7	12.44	8.29	2.37
pineal gland, adult, donor10258	10377-105G8	14.42	8.78	2.51
pituitary gland - adult, donor10196	10180-103C9	9.11	9.11	4.05
pituitary gland, adult, donor10252	10162-103A9	21.37	5.73	2.08
pituitary gland, adult, donor10258	10378-105G9	17.88	3.40	2.55
placenta, adult, pool1	10021-101D3	14.94	3.98	1.72
plasma cell leukemia cell line:ARH-77	10840-111E3	45.29	8.61	4.37
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	13.38	4.51	1.87
pons, adult, pool1	10033-101E6	13.51	6.28	4.13
postcentral gyrus, adult, pool1	10032-101E5	15.78	6.10	3.92
promyelocytes/myelocytes PMC, donor1	12132-128D8	64.83	8.37	14.64
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	16.52	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	56.81	23.45	8.74
prostate cancer cell line:PC-3	10439-106E7	30.49	8.17	4.90
prostate, adult, pool1	10022-101D4	12.70	3.81	2.72
putamen, adult, donor10196	10176-103C5	13.46	7.32	2.60
putamen, adult, donor10252	10152-102I8	19.61	11.76	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	7.65	2.19	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	10.87	4.83	5.32
putamen, newborn, donor10223	10365-105F5	3.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	22.11	2.04	2.33
rectum, fetal, donor1	10067-101I4	27.82	4.17	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	11.66	4.45	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	3.31	0.41	0.00
retina, adult, pool1	10030-101E3	17.10	7.55	2.48
retinoblastoma cell line:Y79	10475-106I7	19.74	5.20	4.94
rhabdomyosarcoma cell line:KYM-1	10787-110H4	27.54	9.47	3.57
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	29.53	11.25	4.78
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.19	2.27	0.76
salivary acinar cells, donor1	11771-123I7	10.04	1.13	1.29
salivary acinar cells, donor2	11772-123I8	12.67	3.44	2.34
salivary acinar cells, donor3	11773-123I9	11.92	2.65	1.99
salivary gland, adult, pool1	10093-102C3	29.17	8.58	6.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	16.61	5.23	2.28
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	20.57	6.70	3.06
seminal vesicle, adult	10201-103F3	37.03	13.23	7.41
serous adenocarcinoma cell line:JHOS-2	10639-108I9	15.79	5.10	3.16
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.80	1.51	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	21.07	2.01	7.02
serous cystadenocarcinoma cell line:HTOA	10693-109F9	14.51	2.96	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	35.26	6.30	6.30
signet ring carcinoma cell line:NUGC-4	10483-107A6	34.32	12.26	8.26
skeletal muscle - soleus muscle, donor1	10282-104F3	44.69	1.42	2.84
skeletal muscle, adult, pool1	10023-101D5	35.62	2.76	1.80
skeletal muscle, fetal, donor1	10066-101I3	19.10	3.02	0.00
skin, adult, donor1	10074-102A2	20.36	13.57	0.00
skin, fetal, donor1	10065-101I2	21.46	5.68	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	89.38	32.35	16.68
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	39.72	11.03	5.04
small cell lung carcinoma cell line:DMS 144	10841-111E4	22.36	0.77	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	47.80	17.47	8.41
small cell lung carcinoma cell line:NCI-H82	10842-111E5	19.62	1.61	2.73
small cell lung carcinoma cell line:WA-hT	10562-108A4	48.81	30.07	8.28
small intestine, adult, pool1	10024-101D6	24.37	6.81	3.34
small intestine, fetal, donor1	10064-101I1	19.16	6.63	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	27.18	8.21	3.59
smooth muscle, adult, pool1	10048-101G3	20.68	3.10	1.81
somatostatinoma cell line:QGP-1	10781-110G7	47.98	13.13	7.77
spinal cord - adult, donor10196	10181-103D1	11.01	5.51	0.23
spinal cord, adult, donor10252	10159-103A6	11.83	7.49	1.97
spinal cord, adult, donor10258	10369-105F9	11.07	2.77	0.69
spinal cord, fetal, donor1	10056-101H2	28.05	7.32	3.05
spinal cord, newborn, donor10223	10359-105E8	16.07	2.30	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	11.95	3.88	1.64
spleen, adult, pool1	10025-101D7	9.14	2.97	2.31
spleen, fetal, pool1	10044-101F8	10.33	3.34	1.83
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.42	4.04	1.97
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	18.99	5.89	1.14
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	34.60	11.18	4.54
squamous cell carcinoma cell line:T3M-5	10616-108G4	17.20	2.35	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	31.85	3.94	2.25
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	24.15	2.97	3.81
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	11.85	2.96	0.85
stomach, fetal, donor1	10062-101H8	44.85	7.48	3.20
submaxillary gland, adult	10202-103F4	31.90	6.84	5.13
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	13.29	5.61	1.04
substantia nigra, adult, donor10258	10371-105G2	12.41	5.69	4.66
substantia nigra, newborn, donor10223	10358-105E7	9.89	4.24	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	23.61	4.59	4.13
temporal lobe, adult, pool1	10031-101E4	17.80	6.78	4.49
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	14.25	1.42	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	10.55	2.64	0.44
tenocyte, donor1	11763-123H8	10.82	2.44	3.14
tenocyte, donor2	11765-123I1	7.63	4.20	1.53
tenocyte, donor3	11768-123I4	15.94	3.34	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	23.62	2.21	2.89
teratocarcinoma cell line:NCR-G1	10798-110I6	29.13	9.40	4.93
teratocarcinoma cell line:PA-1	10807-111A6	18.44	1.08	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	21.07	2.54	2.92
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	12.48	1.51	2.27
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	9.05	0.65	1.64
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	13.03	1.63	2.61
testis, adult, pool1	10026-101D8	14.60	7.95	3.33
testis, adult, pool2	10096-102C6	17.14	8.12	4.06
thalamus - adult, donor10196	10168-103B6	19.87	2.21	2.21
thalamus, adult, donor10252	10154-103A1	12.66	4.06	2.19
thalamus, adult, donor10258, tech_rep1	10370-105G1	4.62	3.08	7.70
thalamus, adult, donor10258, tech_rep2	10370-105G1	16.63	8.07	2.14
thalamus, newborn, donor10223	10366-105F6	6.33	2.30	0.58
throat, adult	10209-103G2	26.96	5.49	2.00
throat, fetal, donor1	10061-101H7	26.20	5.18	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	32.99	7.55	4.17
thymus, adult, pool1	10027-101D9	23.66	4.87	2.98
thymus, fetal, pool1	10043-101F7	22.24	6.65	2.49
thyroid carcinoma cell line:KHM-5M	10776-110G2	14.49	1.33	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	44.42	9.22	5.45
thyroid, adult, pool1	10028-101E1	19.04	7.74	2.61
thyroid, fetal, donor1	10060-101H6	28.74	4.75	3.16
tongue epidermis (fungiform papillae), donor1	10288-104F9	52.35	3.08	3.08
tongue, adult	10203-103F5	36.75	6.28	2.79
tongue, fetal, donor1	10059-101H5	40.20	8.28	2.76
tonsil, adult, pool1	10047-101G2	18.63	4.51	1.90
trachea, adult, pool1	10029-101E2	13.01	3.35	2.62
trachea, fetal, donor1	10058-101H4	20.39	5.77	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	13.82	5.31	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	28.88	11.65	4.36
transitional-cell carcinoma cell line:JMSU1	10492-107B6	20.06	6.74	5.01
tridermal teratoma cell line:HGRT	10694-109G1	22.83	5.71	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	29.80	6.26	4.99
umbilical cord, fetal, donor1	10057-101H3	25.04	2.09	0.00
uterus, adult, pool1	10100-102D1	11.43	4.27	1.02
uterus, fetal, donor1	10055-101H1	13.31	2.56	1.54
vagina, adult	10204-103F6	4.52	2.58	0.65
vein, adult	10191-103E2	21.04	5.70	2.63
xeroderma pigentosum b cell line:XPL 17	10563-108A5	14.69	2.94	1.60